James Willerson
Credentials: · ·
History
- 1968–1971
Cardiovascular Disease
- 1965–1968
Internal Medicine
- 1961–1965
Research
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
New England Journal of Medicine · 2008 · 5,373 citations
Review · Circulation · 2003 · 1,966 citations
Direct proinflammatory effect of C-reactive protein on human endothelial cells
Circulation · 2000 · 1,549 citations
197 papers
- RP
94 papers
- SL
57 papers · 17 as a resident
56 papers
- FB
52 papers
40 papers · 8 as a fellow
31 papers
28 papers
Grants
- 2007–2021
Cardiovascular Cell Therapy Research Network
National Heart, Lung, and Blood Institute · UM1
Contact PI · $4.8M · Texas Heart Institute
- 2009–2012
New Cardiovascular Research Scientist for Molecular and Cellular Biology Core
National Heart, Lung, and Blood Institute · P30
Contact PI · $1.1M · Texas Heart Institute
- 2007–2012
Cardiovascular Cell Therapy Research Network
National Heart, Lung, and Blood Institute · U01
Contact PI · $1.8M · Texas Heart Institute
- 1985–2004
Molecular and Cellular Mechanisms of Heart Disease
National Heart, Lung, and Blood Institute · T32
Contact PI · $848.3K · University of Texas Hlth Sci Ctr Houston
Clinical trials
- 1983–1990
Thrombolysis in Myocardial Infarction (TIMI)
Completed · Phase 3
National Heart, Lung, and Blood Institute (NHLBI)
- 1977–1985
Multicenter Investigation of Limitation of Infarct Size (MILIS)
Completed · Phase 3
National Heart, Lung, and Blood Institute (NHLBI)